Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: marcher who wrote (9937)	10/27/2020 11:05:37 AM
From: marcher	1 Recommendation Recommended By Glenn Petersen Respond to of 22868

hhs statement about binaxnow: hhs.gov fda august statement: fda.gov atlantic october article: theatlantic.com “...The point I'm trying to make here, and I'll be blunt, is that antigen testing will not and cannot work for asymptomatic screening, and [it] will probably kill a lot of people,” Geoffrey Baird, the acting laboratory-medicine chair at the University of Washington, told us... The [FDA] emergency use authorization only covered testing for people within the first seven days of developing symptoms, when viral loads remain high. ...in the general, symptom-free population, the expected levels of infection are actually quite low, so the false-positive rate could be very high. ...“One branch of the government is saying, ‘Use this test for asymptomatic people,’ and then on the other side, they are saying, ‘Use this test for symptomatic people,’” he said. Baird is particularly anxious that the performance of tests will deteriorate in the field and when applied to asymptomatic people.

To: marcher who wrote (9937)	10/27/2020 11:53:52 AM
From: Moonray	Read Replies (1) \| Respond to of 22868

... they more frequently miss infections or mistakenly designate healthy people as infected... That may be, I wouldn't know. But, as I posted last August, they were the best rapid test around: Message 32903124 This 3-week old Times story is not really talking about rapid testing nor how the administration would look sitting on their 150M doses while there is a need in the country. If the states saw that it was of no value, they wouldn't use it. o~~~ O